further attacks with the object of replacing his inhibitor. A purified inhibitor has been prepared, but so far in insufficient amount for clinical uses.
Dr Stratton has also drawn my attention to the reported beneficial effect of E-aminocaproic acid (EACA). Dr R H Champion: I have treated two brothers with this diagnosis, confirmed by finding the characteristic complement abnormalities (Dr P J Lachmann), with the drug E-aminocaproic acid 30 g daily in a doubleblind cross-over trial lasting three months. In both symptoms were considerably lessened (Champion & Lachmann 1969) . There have been one or two Scandinavian reports of successful (Lundh et al. 1968 ) and unsuccessful (Juhlin & Michaelsson 1969) treatment with this drug. The drug is normally used to inhibit the activators which convert plasminogen to plasmin and is used in the treatment of certain haemorrhagic disorders. Dr A Macdonald: The relationship of urticarial skin lesions to histamine and the vasoactive kinins is not well worked out; Dr R K Winkelmann of the Mayo Clinic recently told us of his work demonstrating the presence of bradykinin in urticarial lesions. I was most interested to hear of the attacks of diarrhoea in this patient, as this symptom is also characteristic of patients with carcinoidosis in whom it is usually attributed to a high circulating level of 5-hydroxytryptamine. Is it possible that there is a metabolic link-up between this patient's condition and carcinoidosis and would Dr Chadfield consider the use of Trasylol in the treatment of acute episodes? This has been used in other forms of urticaria witlh little response but where a life-saving measure is required this might be tried. Man aged 41. Engineer History: Vague malaise, lack of energy and headaches for six years; increased fragility, blistering, scarring and pigmentation of exposed skin for two years; hypertrichosis for 18 months. Previous medical history: Syphilis, aged 18 years; WR now negative. Malaria at 21 years. Duodenal ulcer diagnosed radiographically in 1964.
REFERENCES
Family history: Nil relevant. Two of 5 siblings provided urine and stool specimens which contained normal amounts of porphyrins. Personal history: He is a machinist in light engineering but has been unable to work for two years because of his symptoms. He was a moderately heavy drinker up to five years ago, teetotal since; has never taken barbiturates. Physicalfindings: Slight hirsuties of eyebrowvs and temples; scleroderma-like forehead with several depressed scars; scarring of backs of hands; moderately increased pigmentation; slightly enlarged smooth liver. Abnormal findings in initial investigations: SGOT 108, SGPT 104 units. Bromsulphthalein test: 42 retention at 25 min, 30% retention at 45 min.
Liver biopsy: cirrhosis of finely nodular type; only slight excess of storage iron. Serum iron 194, 200, 213 and 158 ,g/100 ml; Hb 164 g/100 ml; PCV 52%. Skin biopsy (forehead) showed gross collagen and elastotic degeneration with much PAS-positive material in walls of upper dermal capillaries. Dorsum of hand showed an intact sub-epidermal blister without inflammatory reaction. Urinary uro-and copro-porphyrins greatly increased; monochromator testingwheal and flare at 400 nm. Initial ilnvestigation of ironi metabolism: Traiisferrin saturation 65 %; bone marrow aspirate showed excess storage iron; urinary excretion of iron as ferrioxamine after injection of 1 g desferrioxamine, 315 pg/24 hours (normal).
Radio-iron absorption (standard meal), 36 0'O (increased). Plasma iron turnover 0-69 mg/day/ 100 ml blood (normal). Utilization of radio-iron normal (880% at 14 days). Red cell survival normal (by 51Cr over 14 days). Red cell mass 321 ml/kg (normal). Blood volume 65 1 ml/kg (normal). Treatment antd cliniical response: Since February 1968 diet has been supplemented daily by 1 pint (475 ml) of milk, fortified with a raw egg, Casilan, glucose and Abidec.
Commencing on 1.4.68, a venesection of 500 ml was made every two weeks on six occasions, the last venesection being on 14.6.68. Since May 1968 the patient has felt increasing well-being, increased energy and no longer has 'muzzy' headaches. He says darkening and 'tightness' of skin on exposure to sunshine were less marked this summer. Skin fragility has decreased and he has had no further blisters. He is now wrell enouglh to work and undertook home-decorating, havinig felt unable to do so for several years. The thireshold level of response to 400 nm light lhas risen significantly by a factor of at least three (Dr I A Magnus). Biochemical response to treatmenit: The fall of plasma iron and rise in total iron-binding capacity Section of Dermatology during and after treatment are shown in Fig 1. Despite the plasma iron falling to 50 ,ug/100 ml the Hb did not fall below 14-0 g/100 ml nor the PCV below 44%. The progressive fall in the urinary uroporphyrins is also shown in Fig 1 and the commensurate changes in urinary coproporphyrin and ftcal proto-and copro-porphyrin excretion are given in Table 1 . There has been a seven-fold drop in the excretion of all the, porphyrins, and only urinary uroporphyrin output is now outside the normal range. Three months after the last venesection, porphyrin excretion was continuing to fall.
Comment
The assessment of response of this disease to therapy is -strewn with pitfalls for the unwary. Porphyrin excretion and sensitivity to light can fluctuate markedly and spontaneously. Other variables such as alcohol intake, other dietary changes and hospitalization must be considered. Although the previous reports of Ippen (1961) , Schirren (1964) and Epstein & Redeker (1965) documented biochemical as well as clinical improvement they did not make clear whether these variables were controlled. Our patient, in fact, stopped drinking alcohol several years ago. Secondly, he was only hospitalized for 26 hours at a time for treatment, and his diet has remained unchanged throughout except for the protein supplement which he began two months before the first venesection.
In these circumstances we think it reasonable to correlate his clinical and biochemical improvement, although perusal of earlier reports makes it clear that there is an inconstant relationship between clinical, biochemical and photo-biological response to venesection.
Htmosiderosis is frequently seen in porphyria cutanea tarda, but here the evidence for an increase in iron stores was equivocal. Plasma iron was usually just above normal with normal total iron-binding capacity, giving a transferrin saturation of about 65 %. Excess storage iron was seen in the bone marrow aspirate, but biopsy showed only a slight increase in stainable liver iron. Urinary excretion of iron after an injection of desferrioxamine was normal. Removal of 3 litres of blood in 10 weeks was followed by a steep fall in plasma iron below normal and an elevation in total ironbinding capacity, indicating depletion of iron stores. After allowing for absorption of dietary iron over this period and the observed fall in hmmatocrit, the iron stores before venesection may be calculated to have amounted to between 1 0 and 1 25 g, an essentially normal quantity. Absorption of a tracer amount of radioactive iron given with a meal (before venesection) was increased (36%, normal up to 10%) but this increase could not be attributed to increased marrow activity since plasma iron turnover, utilization of radio-iron and red cell survival were all within normal limits. The increase in iron absorption may be due to chronic pancreatitis, but this has not yet been investigated. In spite of repeated hematocrit readings of 52-560% neither the red cell mass nor the blood volume was significantly greater than values predicted from height and weight.
In spite of the absence of significant excess of storage iron, venesection was followed by symptomatic and marked biochemical improvement. That the improvement is related to depletion of iron rather than other factors is suggested by the reported beneficial effect of desferrioxamine (Wohler 1964) . It is conceivable that a mild excess of storage iron in hepatic parenchymal cells might further impair the failure of feed-back control which may be responsible for excessive synthesis of porphyrins in this disease.
